Literature DB >> 27766478

Structural brain changes and all-cause mortality in the elderly population-the mediating role of inflammation.

Uta Hanning1,2, Andreas Roesler3, Annette Peters4, Klaus Berger1, Bernhard T Baune5,6.   

Abstract

While MRI brain changes have been related to mortality during ageing, the role of inflammation in this relationship remains poorly understood. Hence, this study aimed to investigate the impact of MRI changes on all-cause mortality and the mediating role of cytokines. All-cause mortality was evaluated in 268 community dwelling elderly (age 65-83 years) in the MEMO study (Memory and Morbidity in Augsburg elderly). MRI markers of brain atrophy and cerebral small vessel disease (SVD), C-reactive protein (CRP) and a panel of cytokines in serum were assessed. Cox proportional hazard models were used to estimate the association of MRI changes with survival over 9 years. Regression models were used to assess the hypothesis that inflammation is mediating the relationship between MRI-brain changes and mortality. In total, 77 (29 %) deaths occurred during a mean follow up of 9 years. After adjusting for confounders, the degree of global cortical atrophy and the level of the cytokines CRP, TNF-α and IL-8 were of higher significance in study participants who had died at follow-up in comparison to survivors. In Cox proportional hazard models, higher degrees of global cortical atrophy (HR 1.56, p = 0.003) and regional atrophy of the temporal lobe (HR 1.38, p = 0.011) were associated with a significantly increased risk of mortality. Mediation analyses revealed a partial mediation by IL-6 and IL-8 of the effects of global cortical atrophy on mortality. Global cortical brain atrophy is a significant indicator of survival in the elderly. Our study supports a possible role for inflammation in the atrophy pathogenesis. If replicated in other samples, IL-6 and IL-8 level assessment may improve risk prognosis for mortality.

Entities:  

Keywords:  Brain ageing; Epidemiology; Mortality risking; Neuroimaging; Sex differences

Mesh:

Substances:

Year:  2016        PMID: 27766478      PMCID: PMC5266221          DOI: 10.1007/s11357-016-9951-9

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  45 in total

1.  Mediation in experimental and nonexperimental studies: new procedures and recommendations.

Authors:  Patrick E Shrout; Niall Bolger
Journal:  Psychol Methods       Date:  2002-12

2.  Does leukoaraiosis predict morbidity and mortality?

Authors:  D P Briley; S Haroon; S M Sergent; S Thomas
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

Review 3.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

4.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

5.  A single question about prior stroke versus a stroke questionnaire to assess stroke prevalence in populations.

Authors:  K Berger; H W Hense; A Rothdach; B Weltermann; U Keil
Journal:  Neuroepidemiology       Date:  2000 Sep-Oct       Impact factor: 3.282

Review 6.  Isocortical hyperemia and allocortical inflammation and atrophy following generalized convulsive seizures of thalamic origin in the rat.

Authors:  Sima Mraovitch
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

7.  Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis.

Authors:  Ahamad Hassan; Beverley J Hunt; Michael O'Sullivan; Kiran Parmar; John M Bamford; Dennis Briley; Martin M Brown; Dafydd J Thomas; Hugh S Markus
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

8.  Interobserver agreement in the classification of stroke in the physicians' health study.

Authors:  K Berger; C S Kase; J E Buring
Journal:  Stroke       Date:  1996-02       Impact factor: 7.914

9.  Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA.

Authors:  Lisa M Melton; Alexander B Keith; Sue Davis; Arthur E Oakley; James A Edwardson; Christopher M Morris
Journal:  Glia       Date:  2003-10       Impact factor: 7.452

10.  Association between cytokines and cerebral MRI changes in the aging brain.

Authors:  Bernhard T Baune; Gerald Ponath; Matthias Rothermundt; Andreas Roesler; Klaus Berger
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-02-04       Impact factor: 2.680

View more
  2 in total

1.  The Indigenous South American Tsimane Exhibit Relatively Modest Decrease in Brain Volume With Age Despite High Systemic Inflammation.

Authors:  Andrei Irimia; Nikhil N Chaudhari; David J Robles; Kenneth A Rostowsky; Alexander S Maher; Nahian F Chowdhury; Maria Calvillo; Van Ngo; Margaret Gatz; Wendy J Mack; E Meng Law; M Linda Sutherland; James D Sutherland; Christopher J Rowan; L Samuel Wann; Adel H Allam; Randall C Thompson; David E Michalik; Daniel K Cummings; Edmond Seabright; Sarah Alami; Angela R Garcia; Paul L Hooper; Jonathan Stieglitz; Benjamin C Trumble; Michael D Gurven; Gregory S Thomas; Caleb E Finch; Hillard Kaplan
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-11-15       Impact factor: 6.591

Review 2.  Fatty Acids, Antioxidants and Physical Activity in Brain Aging.

Authors:  Hércules Rezende Freitas; Gustavo da Costa Ferreira; Isis Hara Trevenzoli; Karen de Jesus Oliveira; Ricardo Augusto de Melo Reis
Journal:  Nutrients       Date:  2017-11-20       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.